Q4 2025
Released Mar 12, 2026, after the close
10-K filed Mar 12, 2026, 71 days after period end · 0001493152-26-009848
Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$4.73M$4.73M derived+22.2% vs Q4 2024−0.7% vs Q3 2025
Net Income$62.00K$62.00K derived−82.2% vs Q4 2024−81.6% vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$2,761,000+11.6%
Operating Incomederived$18,000−94.3%
Operating Cash Flowderived$185,000−85.8%
Margins · derived
Gross margin58.4%−5.6 pt vs Q4 2024
Operating margin0.4%−7.8 pt vs Q4 2024
Net margin1.3%−7.7 pt vs Q4 2024
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $4.73M | $3.87M | $3.25M | $2.56M |
| Net Income | $62.00K | $349.00K | -$654.00K | -$771.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR